A protocol for cell therapy infusion in neonates

Cell therapies for neonatal morbidities are progressing to early phase clinical trials. However, protocols for intravenous (IV) delivery of cell therapies to infants have not been evaluated. It has been assumed the cell dose prescribed is the dose delivered. Early in our clinical trial of human amni...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Elizabeth K., Wallace, Euan M., Davis, Peter G., Malhotra, Atul, Jacobs, Susan E., Hooper, Stuart B., Lim, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Standards, Protocols, Policies, and Regulations for Cell‐based Therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046110/
https://www.ncbi.nlm.nih.gov/pubmed/33405397
http://dx.doi.org/10.1002/sctm.20-0281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046110/
https://www.ncbi.nlm.nih.gov/pubmed/33405397
http://dx.doi.org/10.1002/sctm.20-0281

Ejemplares similares